Biomarin Pharmaceutical Value At Risk
| BMRN Stock | | | USD 55.03 -0.40 -0.72% |
This dataset for Biomarin Pharmaceutical reflects inputs used in the Value At Risk calculation. All values reflect available price and volume data across reporting intervals. Biomarin Pharmaceutical has a market cap of 10.66 B, operating margin of 22.49%, ROE of 5.94%. Review
Trending Equities for broader portfolio context. The portfolio view reflects current allocation structure. The allocation view reflects recorded position information. A position in Biomarin Pharmaceutical is indicated here. This is part of the broader portfolio composition. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
Our
How to Buy Biomarin Stock guide explains the steps to invest in Biomarin Pharmaceutical stock.
Biomarin Pharmaceutical has current Value At Risk of
-2.40. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -2.40 | |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Biomarin Pharmaceutical takes the leading position in value at risk compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Biomarin Pharmaceutical to Peers
Other Technical Indicators